somapacitan news

All news on somapacitan (also known as Sogroya): plants, production capacities, investments and involved companies.

18 September 2026

Novo Nordisk’s Sogroya recommended by EMA CHMP for idiopathic short stature in children

Once-weekly somapacitan (Sogroya) receives CHMP positive opinion for children with idiopathic short stature; European Commission decision expected later this year.

Who will be producing somapacitan in the future?

Find out with chemXplore Alpha

Learn more